Analyst Reco. Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-07-18 pm EDT			5-day change	1st Jan Change
163.70 ^USD	+0.44%		+4.33%	+13.19%

Jul. 13	Earnings, inflation data confront resilient US stocks rally	RE
Jul. 11	S&P 500 ends down as tariffs sour sentiment	RE

Analyst Reco.

HSBC Adjusts Johnson & Johnson Price Target to $188 From $180, Maintains Buy Rating	Jul. 18	MT
Raymond James Adjusts Price Target on Johnson & Johnson to $174 From $164, Maintains Outperform Rating	Jul. 18	MT
BofA Securities Adjusts Price Target on Johnson & Johnson to $175 From $161, Maintains Neutral Rating	Jul. 17	MT
UBS Adjusts Johnson & Johnson Price Target to $190 From $180, Maintains Buy Rating	Jul. 17	MT
Guggenheim Adjusts Price Target on Johnson & Johnson to $167 From $164, Maintains Neutral Rating	Jul. 17	MT
Bernstein Adjusts Price Target on Johnson & Johnson to $172 From $159, Maintains Market Perform Rating	Jul. 17	MT
Stifel Adjusts Price Target on Johnson & Johnson to $165 From $155, Maintains Hold Rating	Jul. 17	MT
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $176 From $171, Maintains Equalweight Rating	Jul. 17	MT
Barclays Raises Price Target on Johnson & Johnson to $176 From $165, Maintains Equalweight Rating	Jul. 17	MT
Goldman Sachs Raises Price Target on Johnson & Johnson to $185 From $177, Maintains Buy Rating	Jul. 17	MT
Leerink Partners Adjusts Price Target on Johnson & Johnson to $171 From $153, Maintains Market Perform Rating	Jul. 17	MT
Morgan Stanley Raises Price Target on Johnson & Johnson to $176 From $171, Keeps Equalweight Rating	Jul. 17	MT
RBC Lifts Price Target on Johnson & Johnson to $185 From $181, Keeps Outperform Rating	Jul. 17	MT
HSBC Adjusts Johnson & Johnson's Price Target to $180 From $184, Keeps Buy Rating	Jul. 11	MT
Morgan Stanley Adjusts PT on Johnson & Johnson to $171 From $169, Maintains Equalweight Rating	Jul. 10	MT
Leerink Partners Downgrades Johnson & Johnson to Market Perform From Outperform, $153 Price Target	May. 13	MT
Global markets live: Google, Microsoft, Coinbase, Boeing, IAG…	May. 09
Goldman Sachs Adjusts Price Target on Johnson & Johnson to $176 From $172, Maintains Buy Rating	May. 02	MT
HSBC Adjusts Price Target on Johnson & Johnson to $184 From $180, Maintains Buy Rating	Apr. 28	MT
Guggenheim Adjusts Price Target on Johnson & Johnson to $164 From $166, Keeps Neutral Rating	Apr. 21	MT
BofA Securities Adjusts Price Target on Johnson & Johnson to $161 From $159, Maintains Neutral Rating	Apr. 16	MT
Raymond James Adjusts Price Target on Johnson & Johnson to $164 From $162, Keeps Outperform Rating	Apr. 16	MT
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $164, Keeps Equalweight Rating	Apr. 16	MT
Bernstein Adjusts Price Target on Johnson & Johnson to $159 From $158, Keeps Market Perform Rating	Apr. 16	MT
Raymond James Adjusts Price Target on Johnson & Johnson to $162 From $165, Keeps Outperform Rating	Apr. 14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

J&J Expects Tariffs to Cost Company $400 Million

April 15, 2025 at 11:30 am EDT

Johnson & Johnson: A Dose of Resilience Amid Trade Tensions

April 15, 2025 at 09:54 am EDT